Artivion, Inc. (AORT)
19.10
-0.30
(-1.55%)
USD |
NYSE |
Nov 13, 16:00
19.10
0.00 (0.00%)
Pre-Market: 19:59
Artivion Shareholders Equity (Quarterly) : 446.40M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 446.40M |
| June 30, 2026 | 445.58M |
| March 31, 2026 | 450.47M |
| December 31, 2025 | 448.23M |
| September 30, 2025 | 438.69M |
| June 30, 2025 | 419.90M |
| March 31, 2025 | 294.25M |
| December 31, 2024 | 276.20M |
| September 30, 2024 | 304.74M |
| June 30, 2024 | 295.06M |
| March 31, 2024 | 294.98M |
| December 31, 2023 | 281.78M |
| September 30, 2023 | 271.98M |
| June 30, 2023 | 282.51M |
| March 31, 2023 | 279.92M |
| December 31, 2022 | 284.33M |
| September 30, 2022 | 255.11M |
| June 30, 2022 | 281.51M |
| March 31, 2022 | 297.49M |
| December 31, 2021 | 300.73M |
| September 30, 2021 | 311.54M |
| June 30, 2021 | 301.84M |
| March 31, 2021 | 297.33M |
| December 31, 2020 | 328.71M |
| September 30, 2020 | 325.77M |
| Date | Value |
|---|---|
| June 30, 2020 | 296.56M |
| March 31, 2020 | 276.61M |
| December 31, 2019 | 285.70M |
| September 30, 2019 | 277.50M |
| June 30, 2019 | 282.15M |
| March 31, 2019 | 272.62M |
| December 31, 2018 | 275.07M |
| September 30, 2018 | 276.81M |
| June 30, 2018 | 271.49M |
| March 31, 2018 | 280.99M |
| December 31, 2017 | 277.06M |
| September 30, 2017 | 223.36M |
| June 30, 2017 | 219.06M |
| March 31, 2017 | 213.43M |
| December 31, 2016 | 208.98M |
| September 30, 2016 | 204.16M |
| June 30, 2016 | 198.10M |
| March 31, 2016 | 194.16M |
| December 31, 2015 | 155.25M |
| September 30, 2015 | 151.89M |
| June 30, 2015 | 149.54M |
| March 31, 2015 | 148.85M |
| December 31, 2014 | 148.68M |
| September 30, 2014 | 146.86M |
| June 30, 2014 | 145.97M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.03B |
| AngioDynamics, Inc. | 163.96M |
| Alphatec Holdings, Inc. | 21.30M |
| AtriCure, Inc. | 533.22M |
| Baxter International, Inc. | 6.502B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.042B |
| Total Liabilities (Quarterly) | 595.69M |
| Debt to Equity Ratio | 0.9118 |
| Current Ratio | 3.719 |
| Net Debt Paydown Yield | -2.57% |